These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 17392349

  • 1. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
    van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Dijkmans BA, Boers M.
    Ann Rheum Dis; 2007 Jul; 66(7):974-6. PubMed ID: 17392349
    [Abstract] [Full Text] [Related]

  • 2. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.
    van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Kerstens PJ, Dijkmans BA, Boers M.
    Rheumatology (Oxford); 2008 Oct; 47(10):1571-6. PubMed ID: 18710900
    [Abstract] [Full Text] [Related]

  • 3. Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation study.
    van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Kerstens PJ, Dijkmans BA, Boers M.
    J Rheumatol; 2009 Jul; 36(7):1380-6. PubMed ID: 19487259
    [Abstract] [Full Text] [Related]

  • 4. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
    ter Wee MM, den Uyl D, Boers M, Kerstens P, Nurmohamed M, van Schaardenburg D, Voskuyl AE, Lems WF.
    Ann Rheum Dis; 2015 Jun; 74(6):1233-40. PubMed ID: 24818633
    [Abstract] [Full Text] [Related]

  • 5. Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis.
    Rasch LA, van Tuyl LH, Lems WF, Boers M.
    Neuroimmunomodulation; 2015 Jun; 22(1-2):51-6. PubMed ID: 25227967
    [Abstract] [Full Text] [Related]

  • 6. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
    Korthals-de Bos I, Van Tulder M, Boers M, Verhoeven AC, Adèr HJ, Bibo J, Boonen A, Van Der Linden S.
    J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
    [Abstract] [Full Text] [Related]

  • 7. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.
    van Tuyl LH, Lems WF, Voskuyl AE, Kerstens PJ, Garnero P, Dijkmans BA, Boers M.
    Ann Rheum Dis; 2008 Nov; 67(11):1574-7. PubMed ID: 18625629
    [Abstract] [Full Text] [Related]

  • 8. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
    Verschueren P, Esselens G, Westhovens R.
    Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681
    [Abstract] [Full Text] [Related]

  • 9. Treatment of pregnant and non-pregnant rheumatic patients: a survey among Dutch rheumatologists.
    Vroom F, van de Laar MA, van Roon EN, Brouwers JR, de Jong-van den Berg LT.
    J Clin Pharm Ther; 2008 Feb; 33(1):39-44. PubMed ID: 18211615
    [Abstract] [Full Text] [Related]

  • 10. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.
    Landewé RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, van Denderen JC, Westedt ML, Peeters AJ, Dijkmans BA, Jacobs P, Boonen A, van der Heijde DM, van der Linden S.
    Arthritis Rheum; 2002 Feb; 46(2):347-56. PubMed ID: 11840436
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoïde Artritis.
    Verhoeven AC, Bibo JC, Boers M, Engel GL, van der Linden S.
    Br J Rheumatol; 1998 Oct; 37(10):1102-9. PubMed ID: 9825750
    [Abstract] [Full Text] [Related]

  • 12. Meta-analysis suggests that intensive non-biological combination therapy with step-down prednisolone (COBRA strategy) may also 'disconnect' disease activity and damage in rheumatoid arthritis.
    Boers M, van Tuyl L, van den Broek M, Kostense PJ, Allaart CF.
    Ann Rheum Dis; 2013 Mar; 72(3):406-9. PubMed ID: 23155223
    [Abstract] [Full Text] [Related]

  • 13. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.
    Hoekstra M, van de Laar MA, Bernelot Moens HJ, Kruijsen MW, Haagsma CJ.
    J Rheumatol; 2003 Nov; 30(11):2325-9. PubMed ID: 14677172
    [Abstract] [Full Text] [Related]

  • 14. [Combination therapy in early rheumatoid arthritis: the COBRA study].
    Boers M, Verhoeven AC, van der Linden S.
    Ned Tijdschr Geneeskd; 1997 Dec 13; 141(50):2428-32. PubMed ID: 9555126
    [Abstract] [Full Text] [Related]

  • 15. American College of Rheumatology criteria for improvement in rheumatoid arthritis should only be calculated from scores that decrease on improvement.
    Boers M, Verhoeven AC, van der Linden S.
    Arthritis Rheum; 2001 May 13; 44(5):1052-5. PubMed ID: 11352236
    [Abstract] [Full Text] [Related]

  • 16. Most rheumatologists are conservative in active rheumatoid arthritis despite methotrexate therapy: results of the PRISME survey.
    Saraux A, Devauchelle-Pensec V, Engerran L, Flipo RM.
    J Rheumatol; 2006 Jul 13; 33(7):1258-65. PubMed ID: 16783865
    [Abstract] [Full Text] [Related]

  • 17. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey.
    Maetzel A, Bombardier C, Strand V, Tugwell P, Wells G.
    J Rheumatol; 1998 Dec 13; 25(12):2331-8. PubMed ID: 9858426
    [Abstract] [Full Text] [Related]

  • 18. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
    Pope JE, Hong P, Koehler BE.
    J Rheumatol; 2002 Feb 13; 29(2):255-60. PubMed ID: 11838842
    [Abstract] [Full Text] [Related]

  • 19. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
    Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M, Järvinen P, Ahonen J, Forsberg S, Leirisalo-Repo M, FIN-RACo Trial Group.
    Arthritis Rheum; 2005 Jan 13; 52(1):36-41. PubMed ID: 15641055
    [Abstract] [Full Text] [Related]

  • 20. Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis.
    van Tuyl LH, Boers M, Lems WF, Landewé RB, Han H, van der Linden S, van de Laar M, Westhovens R, van Denderen JC, Westedt ML, Peeters AJ, Jacobs P, Huizinga TW, van de Brink H, Dijkmans BA, Voskuyl AE.
    Ann Rheum Dis; 2010 May 13; 69(5):807-12. PubMed ID: 19451137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.